Back to Search

PGEN

Precigen, Inc. Common Stock
Data: 2026-09-11
$6.85
Price
2.54%
Change
$7.72
52W High
$2.99
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

42.4

AI Score

HOLD

0.39

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

PGEN Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

PGEN Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

PGEN Options - Sort by Max open Interest (near term)

13th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PGEN Daily Out of Money Options - Sort by Max open Interest (near term)

13th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PGEN Daily In the Money Options - Sort by Max open Interest (near term)

13th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PGEN Most Active Options by Volume(near term)

13th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
PGEN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PGEN Stock Summary

Last updated Sep 11, 2026

PGEN is currently trading at $6.85, positioned above its 200-day moving average of $4.7, indicating a long-term uptrend. The stock has a 52-week range of $2.99 to $7.715.

Technical Analysis: The 50-day moving average stands at $6.29, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 52.316, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.045, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PGEN at 42.4/100 with a HOLD recommendation.

PGEN (Precigen, Inc. Common Stock) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 52.316
CMF (20) 0.045
ROC (10) -4.729
ADX (14) 22.767
Indicator Value
MACD (12,26,9) 0.143
AROONOSC (14) -71.429
WILLAMS %R (14) -73.617
MFI (14) 52.144

PGEN Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Sep 04 Gravestone Doji Bullish 55.2% +2.2 pts 21200
Sep 01 Inverted Hammer Bullish 56.4% +3.4 pts 19834

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Precigen, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

PGEN Moving Averages Analysis

Precigen, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026

Precigen, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026

PGEN (Precigen, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 6.92
20 6.97
30 6.9
50 6.29
100 5.35
200 4.7

PGEN Fundamental Analysis

P/E (Forward) 15.4321
P/E (Trailing) --
Market Cap ($) 2.4 billion
Earnings/Share ($) -1.05
Net Profit Margin (%) -1.8398
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.2203
EPS Estimate Next Year ($) 0.6824
WallStreet Target Price ($) 14.50
Most Recent Quarter

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.